HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohammed Al-Adhami Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

8/2008Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohammed Al-Adhami Research Topics

Disease

7Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
05/2024 - 09/2022
6Hemolysis
04/2024 - 09/2022
4Fatigue
05/2024 - 09/2022
4Chronic Disease (Chronic Diseases)
05/2024 - 09/2022
3Anemia
05/2024 - 08/2008
2Thrombosis (Thrombus)
04/2024 - 09/2022
2Injection Site Reaction
09/2022 - 08/2008
2Neoplasms (Cancer)
09/2022 - 09/2012
1Rare Diseases (Rare Disease)
01/2023
1Nasopharyngitis
09/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Breast Neoplasms (Breast Cancer)
09/2012
1Thrombocytopenia (Thrombopenia)
08/2008
1Neutropenia
08/2008
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2008
1Infections
11/2007
1Chronic Hepatitis C
11/2007
1Persistent Infection
11/2007

Drug/Important Bio-Agent (IBA)

8pegcetacoplanIBA
05/2024 - 09/2022
5eculizumabFDA Link
12/2023 - 09/2022
4Hemoglobins (Hemoglobin)IBA
05/2024 - 09/2022
4Complement System Proteins (Complement)IBA
04/2024 - 09/2022
4Complement Inactivating AgentsIBA
12/2023 - 09/2022
3ravulizumabIBA
12/2023 - 09/2022
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2024 - 01/2023
2OligodeoxyribonucleotidesIBA
08/2008 - 11/2007
2Toll-Like Receptor 9IBA
08/2008 - 11/2007
1Complement C5 (Complement 5)IBA
01/2023
1Complement C3 (C3 Complement)IBA
01/2023
1Docetaxel (Taxotere)FDA Link
01/2020
1enzalutamideIBA
01/2020
1AnthracyclinesIBA
09/2012
1P 11 (P-11)IBA
09/2012
1Formaldehyde (Formol)FDA Link
09/2012
1Keratins (Keratin)IBA
09/2012
1Methotrexate (Mexate)FDA LinkGeneric
09/2012
1ParaffinIBA
09/2012
1A-Form DNA (A-DNA)IBA
09/2012
1PlatinumIBA
08/2008
1taxaneIBA
08/2008
1ProMune (CpG 7909)IBA
08/2008
1Toll-Like Receptors (Toll-Like Receptor)IBA
08/2008
1CPG 10101IBA
11/2007
1Antiviral Agents (Antivirals)IBA
11/2007

Therapy/Procedure

7Therapeutics
05/2024 - 09/2012
2Drug Therapy (Chemotherapy)
09/2012 - 08/2008
1Castration
01/2020
1Palliative Care (Palliative Therapy)
09/2012